Delivery Order SPE2DB22D1017-SPE2DB24FF3RV

Award Date 3/4/24
Potential Completion Date 3/5/24
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $4,760.80 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,145.99 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the provision of the pharmaceutical product TRULICITY 4.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,161.12 contract is for the supply of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a $6,251.40 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4565066471 TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,306.26 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp as the sole prime contractor. The IDC, which has no set-aside designation, serves as the...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $5,805.60 to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical...
The U.S. Defense Logistics Agency has awarded a firm fixed price delivery order contract worth $2,902.80 to Amerisourcebergen Drug Corp, through its Corporate Office division, for the supply of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies in support of military...
The U.S. Defense Logistics Agency (DLA) awarded a $15,069.21 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This award is under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $13,933.44 firm fixed price delivery order contract to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00, to deliver a comprehensive range of medications and medical supplies to support military...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML pharmaceuticals. The $13,002.84 contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a range of pharmaceutical products and medical supplies to DLA Troop Support Medical in support of military...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF3RV
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,886.82 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies in support of military treatment programs and facilities worldwide. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which has a performance period through March 5, 2024.

Generated 6/3/24, 9:33 AM